A detailed history of Pointe Capital Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Pointe Capital Management LLC holds 3,542 shares of NVS stock, worth $343,857. This represents 0.24% of its overall portfolio holdings.

Number of Shares
3,542
Previous 3,842 7.81%
Holding current value
$343,857
Previous $409,000 0.49%
% of portfolio
0.24%
Previous 0.26%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$106.13 - $120.89 $31,839 - $36,267
-300 Reduced 7.81%
3,542 $407,000
Q1 2024

May 07, 2024

SELL
$95.27 - $108.47 $33,535 - $38,181
-352 Reduced 8.39%
3,842 $371,000
Q4 2023

Feb 06, 2024

BUY
$92.27 - $101.54 $3,967 - $4,366
43 Added 1.04%
4,194 $423,000
Q3 2023

Nov 07, 2023

BUY
$94.73 - $105.13 $1,989 - $2,207
21 Added 0.51%
4,151 $422,000
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $5,181 - $5,874
56 Added 1.37%
4,130 $416,000
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $1,920 - $2,227
-24 Reduced 0.59%
4,074 $374,000
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $15,110 - $18,504
-200 Reduced 4.65%
4,098 $372,000
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $4,028 - $4,712
54 Added 1.27%
4,298 $327,000
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $35,729 - $40,416
446 Added 11.74%
4,244 $372,000
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $11,955 - $13,219
150 Added 4.11%
3,798 $332,000
Q3 2021

Oct 29, 2021

BUY
$81.78 - $95.14 $3,271 - $3,805
40 Added 1.11%
3,648 $298,000
Q2 2021

Aug 13, 2021

BUY
$85.24 - $94.15 $10,655 - $11,768
125 Added 3.59%
3,608 $329,000
Q1 2021

May 11, 2021

SELL
$83.5 - $98.47 $5,511 - $6,499
-66 Reduced 1.86%
3,483 $298,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $11,007 - $13,314
-141 Reduced 3.82%
3,549 $335,000
Q3 2020

Nov 05, 2020

BUY
$82.14 - $91.0 $9,856 - $10,920
120 Added 3.36%
3,690 $321,000
Q1 2020

May 11, 2020

SELL
$70.67 - $99.01 $18,798 - $26,336
-266 Reduced 6.93%
3,570 $294,000
Q4 2019

Feb 04, 2020

SELL
$84.35 - $95.37 $1,265 - $1,430
-15 Reduced 0.39%
3,836 $363,000
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $2,395 - $2,639
-28 Reduced 0.72%
3,851 $335,000
Q2 2019

Aug 08, 2019

SELL
$75.4 - $92.8 $9,726 - $11,971
-129 Reduced 3.22%
3,879 $354,000
Q1 2019

May 13, 2019

SELL
$75.32 - $86.15 $5,046 - $5,772
-67 Reduced 1.64%
4,008 $385,000
Q4 2018

Feb 06, 2019

SELL
$73.66 - $82.02 $3,462 - $3,854
-47 Reduced 1.14%
4,075 $350,000
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $30,792 - $35,617
460 Added 12.56%
4,122 $355,000
Q2 2018

Aug 10, 2018

BUY
$64.91 - $73.36 $49,915 - $56,413
769 Added 26.58%
3,662 $277,000
Q1 2018

May 10, 2018

BUY
$70.39 - $84.15 $3,519 - $4,207
50 Added 1.76%
2,893 $234,000
Q4 2017

Jan 12, 2018

SELL
$72.33 - $77.64 $10,777 - $11,568
-149 Reduced 4.98%
2,843 $239,000
Q3 2017

Oct 16, 2017

BUY
$74.14 - $77.27 $221,826 - $231,191
2,992
2,992 $257,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Pointe Capital Management LLC Portfolio

Follow Pointe Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pointe Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pointe Capital Management LLC with notifications on news.